Thomas Joseph Russo - 10 Nov 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Financial Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Nov 2022
Net transactions value
$0
Form type
4
Filing time
14 Nov 2022, 18:05:27 UTC
Previous filing
02 Aug 2022
Next filing
15 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 10 Nov 2022 Common Stock 100,000 $2.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-third (1/3rd) of the shares subject to the option shall vest on each of the first three anniversaries of November 10, 2022, subject to the reporting person's continued service through the applicable vesting date.